| 0 (0%) | 11-11 17:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 20.18 | 1-year : | 23.57 |
| Resists | First : | 17.28 | Second : | 20.18 |
| Pivot price | 15.58  |
|||
| Supports | First : | 15 | Second : | 13.6 |
| MAs | MA(5) : | 16.39 |
MA(20) : | 15.31 |
| MA(100) : | 14.9 |
MA(250) : | 17.74  |
|
| MACD | MACD : | 0.3 |
Signal : | 0 |
| %K %D | K(14,3) : | 85.1 |
D(3) : | 85.7 |
| RSI | RSI(14): 67 |
|||
| 52-week | High : | 72.37 | Low : | 9.11 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KROS ] has closed below upper band by 0.7%. Bollinger Bands are 67.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 17.15 - 17.24 | 17.24 - 17.3 |
| Low: | 16.1 - 16.21 | 16.21 - 16.28 |
| Close: | 16.73 - 16.91 | 16.91 - 17.02 |
Tue, 11 Nov 2025
KROS: Wells Fargo Lowers Price Target to $23, Maintains Overweig - GuruFocus
Mon, 10 Nov 2025
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High? - Yahoo Finance
Sun, 09 Nov 2025
Earnings Update: Keros Therapeutics, Inc. (NASDAQ:KROS) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance
Fri, 07 Nov 2025
Joseph David Kross - Beaver County Times
Thu, 06 Nov 2025
Wedbush Maintains Keros Therapeutics (KROS) Neutral Recommendation - Nasdaq
Thu, 06 Nov 2025
New Analyst Forecast: $KROS Given $16.0 Price Target - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 3.748e+007 (%) |
| Held by Institutions | 2.7 (%) |
| Shares Short | 4,620 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 1.67e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 8 % |
| Operating Margin | -219.2 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 3.3 % |
| Qtrly Rev. Growth | 49 % |
| Gross Profit (p.s.) | 2.78 |
| Sales Per Share | 2.40041e+008 |
| EBITDA (p.s.) | 2.26186e+008 |
| Qtrly Earnings Growth | 0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 55 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.94 |
| Dividend | 0 |
| Forward Dividend | 3.82e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|